LAN Youling, LI Tianfa, ZHAN Yatong, CHEN Yan'e, GUAN Fuqing, YANG Yang. Effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3/cysteine-aspartic acid-specific protease 1 mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 3-8, 13. DOI: 10.7619/jcmp.20240909
Citation: LAN Youling, LI Tianfa, ZHAN Yatong, CHEN Yan'e, GUAN Fuqing, YANG Yang. Effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3/cysteine-aspartic acid-specific protease 1 mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 3-8, 13. DOI: 10.7619/jcmp.20240909

Effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3/cysteine-aspartic acid-specific protease 1 mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction

More Information
  • Received Date: March 04, 2024
  • Revised Date: May 19, 2024
  • Objective 

    To investigate the effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3 (NLRP3)/cysteine-aspartic acid-specific protease 1 (Caspase-1) mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction (AMI).

    Methods 

    A total of 40 rats were randomly divided into sham operation group, model group, betaloc group (0.9 mg/kg), and combination group (0.9 mg/kg betaloc combined with 6 mL/kg Shenfu Injection), with 10 rats in each group. The rats were treated by gavage continuously for 3 weeks. The levels of serum troponin I (cTnI), creatine kinase-MB (CK-MB), interleukin (IL)-6, IL-1β, and tumor necrosis factor-α (TNF-α) in rats were detected before modeling, after modeling, and at 3 weeks of treatment. Echocardiographic parameters such as left ventricular ejection fraction (LVEF), left ventricular end-systolic diameter(LVESD), left ventricular end-diastolic diameter (LVEDD), and myocardial infarction area were compared among groups after modeling and at 3 weeks of treatment. Real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) and Western blot were used to detect the mRNA and protein expression levels of NLRP3 and Caspase-1 in the myocardium.

    Results 

    Compared with the sham operation group, the levels of cTnI, CK-MB, IL-6, IL-1β, TNF-α, myocardial infarction area, and the expressions of NLRP3 mRNA and Caspase-1 mRNA in the model group were significantly increased after modeling and at 3 weeks of treatment (P < 0.05); compared with the model group, the levels of cTnI, CK-MB, IL-6, IL-1β, TNF-α, myocardial infarction area, and the expressions of NLRP3 mRNA and Caspase-1 mRNA in the betaloc group and the combination group were significantly decreased at 3 weeks of treatment, and the above indicators in the combination group were significantly lower than those in the betaloc group (P < 0.05).

    Conclusion 

    Adjuvant therapy of Shenfu Injection for AMI can further alleviate myocardial cell injury, shorten infarction size, and inhibit inflammatory response and pyroptosis activity.

  • [1]
    邓志杰, 董子洵, 刘家伟, 等. 参附注射液综合评价研究[J]. 中国临床药理学杂志, 2023, 39(24): 3682-3692. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202324030.htm
    [2]
    宋玉莹, 崔琳, 何玉凤, 等. 参附益心颗粒对心肌梗死后心力衰竭大鼠线粒体动力学的影响[J]. 中国实验方剂学杂志, 2024, 30(11): 87-94. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202411011.htm
    [3]
    徐坡, 谢靖, 邵妤, 等. 参附注射液治疗脓毒症相关心肌功能障碍临床观察[J]. 山西中医, 2023, 39(12): 11-14. https://www.cnki.com.cn/Article/CJFDTOTAL-SHIX202312005.htm
    [4]
    CHEN R J, RUI Q L, WANG Q, et al. Shenfu injection attenuates lipopolysaccharide-induced myocardial inflammation and apoptosis in rats[J]. Chin J Nat Med, 2020, 18(3): 226-233.
    [5]
    ZHANG J, HUANG L L, SHI X, et al. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway[J]. Aging, 2020, 12(23): 24270-24287. doi: 10.18632/aging.202143
    [6]
    ZHANG B F, LIU G, HUANG B, et al. KDM3A attenuates myocardial ischemic and reperfusion injury by ameliorating cardiac microvascular endothelial cell pyroptosis[J]. Oxid Med Cell Longev, 2022, 2022: 4622520.
    [7]
    王贝贝, 郭丽叶, 刘姜倩, 等. 针刺联合参附注射液对心脏骤停患者心肺复苏后脑损伤及血流动力学的影响[J]. 中国现代医生, 2023, 61(34): 76-80. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS202334020.htm
    [8]
    刘豫, 高春雁, 武伟, 等. 参附注射液对广西巴马小型猪离体空跳心脏心肌保护的研究[J]. 河北医药, 2023, 45(23): 3554-3558. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ202323007.htm
    [9]
    叶润杰, 黄培红. 基于网络药理学探讨加味参附颗粒治疗慢性心力衰竭的潜在靶点及作用机制[J]. 广州中医药大学学报, 2023, 40(11): 2867-2876. https://www.cnki.com.cn/Article/CJFDTOTAL-REST202311025.htm
    [10]
    刘海燕, 于晶晶, 师志云, 等. 基于PI3K-AKT-mTOR信号通路探讨参附注射液对心力衰竭大鼠的作用及其机制[J]. 现代生物医学进展, 2023, 23(22): 4218-4222. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202322004.htm
    [11]
    WANG X, GUO R F, GUO Y Y, et al. Rationale and design of the RESTORE trial: a multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI[J]. Am Heart J, 2023, 260: 9-17. doi: 10.1016/j.ahj.2023.02.005
    [12]
    CHEN X, LI Y Q, LI J J, et al. Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats[J]. J Ethnopharmacol, 2022, 285: 114841. doi: 10.1016/j.jep.2021.114841
    [13]
    WANG X, HU Y, WANG Y G, et al. CLEC5A knockdown protects against cardiac dysfunction after myocardial infarction by suppressing macrophage polarization, NLRP3 inflammasome activation, and pyroptosis[J]. Biochim Biol Cell, 2021, 99(5): 655-665. doi: 10.1139/bcb-2020-0672
    [14]
    LI Y X, WANG Y, GUO H, et al. IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis[J]. Mol Med Rep, 2021, 25(2): 40. doi: 10.3892/mmr.2021.12556
    [15]
    MAO Q, LIANG X L, ZHANG C L, et al. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis[J]. Stem Cell Res Ther, 2019, 10(1): 393. doi: 10.1186/s13287-019-1522-4
    [16]
    范星宇, 廖晓倩, 王梓仪, 等. NLRP3炎症小体介导的细胞焦亡在慢性心力衰竭中的机制及中医药研究进展[J]. 中国中药杂志, 2024, 49(8): 2106-2116. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202408012.htm
    [17]
    原平利, 刘刚, 马兰香, 等. 毛兰素通过抑制NLRP3炎症体介导的细胞焦亡减轻心肌缺血再灌注损伤[J]. 山西医科大学学报, 2023, 54(9): 1200-1207. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYX202309005.htm
    [18]
    SUN W J, LU H Q, LYU L C, et al. Gastrodin ameliorates microvascular reperfusion injury-induced pyroptosis by regulating the NLRP3/caspase-1 pathway[J]. J Physiol Biochem, 2019, 75(4): 531-547. doi: 10.1007/s13105-019-00702-7
    [19]
    YAO F, JIN Z, ZHENG Z H, et al. HDAC11 promotes both NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells[J]. Cell Death Discov, 2022, 8: 112.
    [20]
    JIANG X J, MA C Y, GAO Y B, et al. Tongxinluo attenuates atherosclerosis by inhibiting ROS/NLRP3/caspase-1-mediated endothelial cell pyroptosis[J]. J Ethnopharmacol, 2023, 304: 116011. doi: 10.1016/j.jep.2022.116011
    [21]
    TANG Y S, ZHAO Y H, ZHONG Y, et al. Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS/NLRP3/Caspase-1 signaling pathway[J]. Inflamm Res, 2019, 68(9): 727-738. doi: 10.1007/s00011-019-01256-6
    [22]
    赵雯, 张勇, 张波, 等. 红花黄色素调节NF-κB/NLRP3信号通路对心肌梗死大鼠心肌细胞焦亡和炎性损伤的影响[J]. 河北医学, 2023, 29(1): 25-31. https://www.cnki.com.cn/Article/CJFDTOTAL-HCYX202301005.htm
    [23]
    马迪, 张秀静, 王威, 等. 柴胡加龙骨牡蛎汤含药血清调控NLRP3/Caspase-1通路介导心肌细胞焦亡的研究[J]. 现代中西医结合杂志, 2023, 9(2): 183-187, 204. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJH202302007.htm
    [24]
    张杼惠, 曹蛟, 刘蓉芳, 等. 基于ROS/TXNIP/NLRP3通路的柴胡三参胶囊对心肌缺血再灌注损伤大鼠心肌细胞焦亡的影响[J]. 中国中医药信息杂志, 2023, 30(5): 114-120. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYY202305019.htm
    [25]
    JIA Y F, CUI R X, WANG C, et al. Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway[J]. Redox Biol, 2020, 32: 101534.
    [26]
    YAN H L, LUO B, WU X Y, et al. Cisplatin induces pyroptosis via activation of MEG3/NLRP3/caspase-1/GSDMD pathway in triple-negative breast cancer[J]. Int J Biol Sci, 2021, 17(10): 2606-2621.
    [27]
    JIANG S Q, ZHANG H, LI X, et al. Vitamin D/VDR attenuate cisplatin-induced AKI by down-regulating NLRP3/Caspase-1/GSDMD pyroptosis pathway[J]. J Steroid Biochem Mol Biol, 2021, 206: 105789.
  • Related Articles

    [1]YIN Ying, GAO Yan, YANG Xiaoxin, MA Wenjing, WANG Wei. Application of family-involved nursing model under concept of rapid recovery in perioperative nursing for patients with pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 129-133. DOI: 10.7619/jcmp.20240679
    [2]LU Yanfeng, DAI Jiabao, WU Zhouquan, ZOU Zhiqing. Effect of esketamine on perioperative pain and depression in patients with thoracoscopic pulmonary nodule resection[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 90-94. DOI: 10.7619/jcmp.20234042
    [3]GAO Yan, WANG Wei, YANG Xiaoxin, DING Jiefang, YIN Ying. Precision nursing for patients with visualization technology assisted pulmonary nodule surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 97-100, 106. DOI: 10.7619/jcmp.20233596
    [4]LIN Weiyong, WENG Wenjun. Identification characteristic of benign and malignant pulmonary nodules and differential diagnostic indicators of the infiltration degree of malignant ground-glass nodules[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 14-19. DOI: 10.7619/jcmp.20232071
    [5]WEI Xinqi, RUAN Aichao, YANG Ying, ZHANG Qing. Clinical nursing pathway management in patients with CT-guided thoracoscopic small pulmonary nodules resection[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 120-123. DOI: 10.7619/jcmp.20221144
    [6]LI Juanjuan, LIU Min, YANG Bin, DU Wei, YANG Hongkai, LIAO Yanquan, LI Junhang, WANG Jun. Application of artificial intelligence-assisted pulmonary nodule screening and qualitative diagnosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 8-12. DOI: 10.7619/jcmp.20214698
    [7]CAO Lan, TAO Yujian, ZHAO Yuanlu, ZHANG Pan. Analysis in risk factors of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 38-40, 44. DOI: 10.7619/jcmp.20200457
    [8]LIU Desen, CHEN Xiaochun, ZHU Feng, LIU Yongjie, CHEN Ming, LIU Feng, MA Haitao. Clinical analysis in chest CT and pathology of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2018, (7): 96-98. DOI: 10.7619/jcmp.201807026
    [9]ZHONG Chonghao, SHI Hongcan, SHU Yusheng, SHI Weiping, LU Shichun, SUN Chao. Establishment and clinical verification of a mathematical model foRpredicting the probability of malignancy oRbegin in patients with solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2017, (9): 82-85,93. DOI: 10.7619/jcmp.201709021
    [10]XI Xiaoxiang, LYU Bihong, YE Ting, HE Guangming, CHEN Rui, XU Xiang, WANG Baoguan. Value of serum NSE, Cyfra21-1, CEA and CA125 in diagnosis of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2015, (21): 41-43,51. DOI: 10.7619/jcmp.201521011
  • Cited by

    Periodical cited type(23)

    1. 魏淑敏,陈岩,刘俊婷. 序贯肠内外营养支持辅助治疗急性脑卒中伴吞咽障碍临床观察. 社区医学杂志. 2024(02): 56-59 .
    2. 王子雪. 两种营养护理方案在重症脑梗死患者中的应用. 中国城乡企业卫生. 2024(03): 102-105 .
    3. 谢柏发,邓静,余刚. 早期肠内营养支持疗法在重症脑出血临床治疗中的效果及有效性分析. 基层医学论坛. 2024(10): 76-78+91 .
    4. 吴苑云,范子英,卓月凤. 重症脑出血患者围术期营养支持的现状及研究进展. 现代医学与健康研究电子杂志. 2024(06): 128-131 .
    5. 黄霞,张莉,狄红珍,冯小丹,朱梅. 早期序贯康复护理联合童趣化互动干预对外伤性颅内出血患儿的影响. 护理实践与研究. 2024(06): 821-827 .
    6. 张明,刘逸文,文章. 早期肠内营养乳剂支持疗法治疗重症脑出血患者的临床研究. 广东药科大学学报. 2024(05): 127-131 .
    7. 戴颖,龚丽. 重症脑出血患者应用ADOPT模式护理联合5A护理的效果. 医药前沿. 2024(15): 114-116 .
    8. 郑蕾. 序贯式肠内营养支持对重症脑出血患者营养状况及胃肠道喂养不耐受的影响. 内蒙古医学杂志. 2023(02): 247-249 .
    9. 黄玉琪,刘颖,石改红. ERAS理念指导的护理干预对前列腺增生患者术后康复的影响. 国际医药卫生导报. 2023(07): 1015-1020 .
    10. 任丽敏. 营养支持联合早期运动整合干预对重症脑出血患者早期预后的影响. 中国实用乡村医生杂志. 2023(03): 59-63 .
    11. 周琴,吴晓芳,王敏. 早期微生态肠内营养介入与管理在老年神经外科重症机械通气患者中的应用价值分析. 当代护士(中旬刊). 2023(05): 113-117 .
    12. 刘艳红,葛利越,杨静,蒋大丽. 基于快速康复外科理念的分阶段护理干预联合序贯性EEN与康复锻炼对胃癌患者预后的影响. 海军医学杂志. 2023(06): 646-648 .
    13. 李纲. 肠内营养序贯治疗对重症急性脑梗死合并吞咽功能障碍患者营养状态不良反应及并发症的影响. 中国药物与临床. 2022(02): 163-165 .
    14. 赵轶梁. 早期肠内外营养联合支持在重症脑卒中患者中的应用效果观察. 实用中西医结合临床. 2022(01): 70-71+78 .
    15. 崔益明,金守兵,陈彩霞. 早期肠内营养支持疗法在重症脑出血临床治疗中的效果. 吉林医学. 2022(04): 1044-1045 .
    16. 贾亚杰,姚明. 肠内营养支持与肠外营养支持序贯治疗危重患者的临床价值. 中国医药科学. 2022(11): 187-189+196 .
    17. 黄涵. 序贯性肠内营养在重症脑出血患者治疗中的应用效果分析. 中国社区医师. 2021(01): 20-21 .
    18. 王德荣. 围手术期序贯性肠内营养在肝段切除患者中的应用及护理. 中外医学研究. 2021(15): 179-181 .
    19. 王英华. 肠内营养支持结合个性化营养护理对原发性脑出血患者病情康复效果的影响. 中外医疗. 2021(21): 164-167+171 .
    20. 汪海滔,陈伟鹏,邓惠森. 序贯性肠内营养在重症脑出血患者治疗中的应用效果分析. 吉林医学. 2021(10): 2476-2477 .
    21. 杜欢,钱坤,姚淑芳. 序贯性早期肠内营养在重症脑出血患者中的应用效果. 中国民康医学. 2021(20): 39-41 .
    22. 庞春. 术后早期应用肠内营养治疗重症脑出血患者术后腹泻的效果. 中国医药指南. 2020(31): 70-71 .
    23. 冯二艳,罗书引,潘幸尧,郑红艳,丁宗励. 肠内序贯营养支持联合益生菌对重型颅脑损伤患者营养状况及胃肠功能障碍的改善作用研究. 解放军预防医学杂志. 2020(09): 127-130 .

    Other cited types(0)

Catalog

    Article views (160) PDF downloads (21) Cited by(23)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return